Statin therapy in critical illness: an international survey of intensive care physicians’ opinions, attitudes and practice

Manu Shankar-Hari, Peter S. Kruger, Stefania Di Gangi, Damon C. Scales, Gavin D. Perkins, Danny F. McAuley, Marius Terblanche

Research output: Contribution to journalArticlepeer-review

Abstract

Pleotropic effects of statins on inflammation are hypothesised to attenuate the severity of and possibly prevent the occurrence of the host inflammatory response to pathogen and infection-related acute organ failure. We conducted an international survey of intensive care physicians in Australia, New Zealand (ANZ) and United Kingdom (UK). The aims of the survey were to assess the current prescribing practice patterns, attitudes towards prescribing statin therapy in critically ill patients and opinions on the need for an interventional trial of statin therapy in critically ill patients.
Original languageEnglish
JournalBMC clinical pharmacology
Volume12
Issue number1
DOIs
Publication statusPublished - 28 Jun 2012

Fingerprint

Dive into the research topics of 'Statin therapy in critical illness: an international survey of intensive care physicians’ opinions, attitudes and practice'. Together they form a unique fingerprint.

Cite this